Phenotypic evolution of classic 21-hydroxylase deficiency

Clinical Endocrinology

Volumn 45, Issue 1, 1996, Pages 103-109

  Hoffman, William H ^a   Shin, Myung Y ^b   Donohoue, Patricia A ^c   Helman, Sandra W ^a   Brown, Stephanie L ^c   Rosculet, George ^b   Mahesh, Virendra B ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b Children's Hospital of Michagen   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL HYPERPLASIA; ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; MUTATION; PRIORITY JOURNAL; STEROID 21 MONOOXYGENASE DEFICIENCY;

ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; BASE SEQUENCE; COMPLEMENT C4; EXONS; FEMALE; HUMANS; INTRONS; MOLECULAR SEQUENCE DATA; MUTATION; PHENOTYPE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE ANALYSIS, DNA; STEROID 21-HYDROXYLASE; TREATMENT REFUSAL;

EID: 0030011162     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.1996.tb02067.x     Document Type: Article

References (40)

1. Baranetsky, N.G., Zipser, R.D., Goebelsmann, U., Kurman, R.J., March, C.M., Morimoto, I. & Stanczyk, F.Z. (1979) Adrenocorticotropin-dependent virilizing paraovarian tumors in Nelson's syndrome. Journal of Clinical Endocrinology and Metabolism, 49, 381-386.
2. Belmin, J., Levy, B.I. & Michel, J.B. (1994) Changes in the renin angiotensin aldosterone axis in later life. Drugs and Aging, 5, 391-400.
3. Boyum, A. (1968) Isolation of leukocytes from human blood. Further observations - methylcellulose, dextran, and ficoll as erythrocyte aggregating agents. Scandinavian Journal of Clinical Investigation, 97 (Suppl.), 31-49.
4. Chang, S.F. & Chung, B.C. (1995) Difference in transcriptional activity of two homologous CYP21A genes. Molecular Endocrinolog, 9, 1330-1336.
5. Degenhart, H.J., Visser, H.K.A., Wilmink, R. & Croughs, W. (1965) Aldosterone and cortisol secretion rates in infants and children with congenital adrenal hyperplasia suggesting different 21-hydroxylation defects in salt-losers and nonsalt-lowers. Acta Endocrinologica, 48, 587-601.
6. Donohoue, P.A., Collins, M.M., Van Dop, C. and Migeon, C.J. (1988) Oligonucleotidc probes identify single-base transversion in congenital adrenal hyperplasia. Endocrine Society, p. 256 (abstr. 944).
7. Donohoue, P.A., Parker, K. & Migeon, C.J. (1995) Congenital Adrenal Hyperplasia. In Metabolic and Molecular Basis of Inherited Disease. Volume 2 (eds C.R. Scriver, A.L. Beaudet, W.S. Sly & D. Valle), pp. 2929-2966, McGraw-Hill, New York.
8. Donohoue, P.A., Van Dop, C., McLean, R.H., White, P.C., Jospe, N. & Migeon, C.J. (1986) Gene conversion in salt-losing congenital adrenal hyperplasia with absent complement C4B protein. Journal of Clinical Endocrinology and Metabolism, 62, 995-1002.
9. Dupont, B., Virdis, R., Lerner, A.J., Nelson, C., Pollack, M.S., and New, M.I. (1984) Distinct HLA B antigen associations for the salt-wasting and simple virilizing forms of congential adrenal hyperplasia due to 21-hydroxylase deficiency. In Histocompatibility Testing (Eds E.D. Albert, M.P. Baur & W.R. Mayr), p 660, Springer-Verlag, Berlin.
10. Hansen, J.A., Fu, S.M., Antonelli, P., Kamoun, M., Hurley, J.N., Winchester, R.T., Dupont, B. & Kunkel, H.G. (1979) B-lymphoid cell lines derived from HLA-D homozygous donors. Immunogenetics, 8, 51-64.
11. Higashi, Y., Tanae, A., Inoue, H., Hiromasa, T. & Fujii-Kuriyama, Y. (1988) Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans: Possible gene conversion products. Proceedings of the National Academy of Sciences, 85, 7486-7490.
12. Hollenberg, N.K., Chenitz, W.R., Adams, D.F. & Williams, G.H. (1974) Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. Journal of Clinical Investigation, 54, 34-42.
13. Horner, J.M., Hintz, R. L. & Luetscher, J.A. (1979) The role of renin and angiotensin in salt-losing, 21-hydroxylase-deficient congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism, 48, 776-783.
14. Jacobs, D.R., Vander Poll, J., Gabrilove, J.L. & Soffer, L.J. (1961) 17-hydroxyprogesterone a salt-losing steroid: relation to congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism, 21, 909-922.
15. Johnstone, E.M., Smith, D.P., Hsuing, H.M. & Little, S.P. (1991) Comments (US Biochemical Corporation) 18, 22-23.
16. Jospe, N., Donohoue, P.A., Van Dop, C., McLean, R.H., Bias, W.B. & Migeon, C.J. (1987) Prevalence of polymorphic 21-hydroxylase gene (CA21HB) mutations in salt-losing congential adrenal hyperplasia. Biochemical and Biophysical Research Communications, 142, 798-804.
17. Kasperlik-Zaluska, A.A., Nielubowicz, J., Wislawski, J., Hartwig, W., Zalusak, J., Jeske, W. & Migdalska B. (1983) Nelson's Syndrome: Incidence and prognosis. Clinical Endocrinology, 19, 693-698.
18. Kohn, B., Enerio, D., Patel, S. & Speiser, P.W. (1994) Splicing mutation in CYP21 associated with delayed presentation of salt-wasting congenital adrenal hyperplasia. Endocrine Society, p. 223 (abstr. 92).
19. Kyllo, J.H., Collins, M.M. & Donohoue, P.A. (1995) Constitutive human steroid 21-hydroxylase promoter gene and pseudogene activity in steroidogenic and nonsteroidogenic cells with the luciferase gene as a reporter. Endocrine Research, 21, 777-791.
20. Landau, R.L. & Lugibihl, K. (1958) Inhibition of the sodium retaining influence of aldosterone by progesterone. Journal of Clinical Endocrinology and Metabolism, 18, 1237-1245.
21. MacDonald, P.C., Cutrer, S., MacDonald, S.C., Casey, M.L. & Parker, C.R. (1982) Regulation of extra adrenal steroid 21-hydroxylase activity. Journal of Clinical Investigation, 69, 469-478.
22. Migeon, C.J. & Donohoue, P. (1994) Adrenal disorders. In Wilkins: The Diagnosis and Treatment of Endocrine Disorders in Children and Adolescents (eds M.S. Kappy, R.M. Blizzard & C.J. Migeon), pp. 717-856. Charles C. Thomas, Springfield.
23. Mulaikal, R.M., Migeon, C.J. & Rock, J.A. (1987) Fertility rates in female patients with congenital adrenal hyperplasia due to a 21-hydroxylase deficiency. New England Journal of Medicine, 316, 178-182.
24. Rayyis, S.S. & Horton, R. (1971) Effect of angiotensin II on adrenal and pituitary function in man. Journal of Clinical Endocrinology and Metabolism, 32, 539-546.
25. Rozenwaks, Z., Lee, P.A., Jones, G.S., Migeon, C.J. & Wentz, A.C. (1979) An attenuated form of congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism, 49, 335-339.
26. Scheithauer, B.W., Kovacs, K. & Randall, R.V. (1983) The pituitary gland in untreated Addison's disease. Archives of Pathology and Laboratory Medicine, 107, 484-487.
27. Schulze, E., Scharer, G., Rogatzki, A., Priebe, L., Lewicka, S., Bettendorf, M., Hoepffner, W., Heinrick, U.E. & Schwabe, U. (1995) Divergence between genotype and phenotype in relatives of patients with the intron 2 mutation of steroid 21-hydroxylase. Endocrine Research, 21, 359-364.
28. Siegel, S.F., Lee, P.A. & Trucco, M. (1994) The splicing mutation in 21-hydroxylase deficiency: A spectrum of phenotypes. Endocrine Society, p. 224 (abstr. 93).
29. Speiser, P.W., Agdere, L., Ueshiba, H., White, P.C. & New, M.I. (1991) Aldosterone synthesis in salt-wasting congenital adrenal hyperplasia with complete absence of adrenal 21-hydroxylase. New England Journal of Medicine, 324, 145-149.
30. Speiser, P.W., New, M.I., Tannin, G.M., Pickering, D., Yang, S.Y. & White, P.C. (1992) Genotype of Yupik Eskimos with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Human Genetics, 88, 647-648.
31. Speiser, P.W., New, M.I. & White, P.C. (1988) Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14, DR1. New England Journal of Medicine, 319, 19-23.
32. Stoner, E., Dimartino-Nardi, J., Kuhnle, U., Levine, L.S., Oberfield, S.E. & New. M.I. (1986) Is salt wasting in congenital adrenal hyperplasia due to the same gene as the fasciculata defect? Clinical Endocrinology, 24, 9-20.
33. Tajima, T., Fujeida, K., Nakayama, K. & Fujii-Kuriyama, Y. (1993) Molecular analysis of patient and carrier genes with congenital steroid 21-hydroxylase deficiency by using polymerase chain reaction and single strand conformational polymorphism. Journal of Clinical Investigation, 92, 2182-2190.
34. Tuck, M.L., Sowers, J.R., Asp, N.D., Viosca, S.P., Berg, G. & Mayes, D.M. (1981) Mineralocorticoid response to low dose adrenocorticotropin infusion. Journal of Clinical Endocrinology and Metabolism, 52, 440-446.
35. Watt, G.C., Harrap, S.B., Foy, C.J., Holton, D.W., Edwards, H.V., Davidson, H.R., Connor, J.M., Lever, A.F. & Fraser, R. (1992) Abnormalities of glucocorticoid metabolism and the reninangiotensin system: a four corners approach to the identification of genetic determinants of blood pressure. Journal of Hypertension, 10, 473-482
36. White, P.C. (1994) Mechanisms of disease: Disorders of aldosterone biosynthesis and action. New England Journal of Medicine, 331, 250-258.
37. White, P.C., Grossberger, D., Onufer, B.J., Chaplin, D.D., New, M.I., DuPont, B. & Strominger, J.L. (1985) Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proceedings of the National Academy of Sciences USA, 82, 1089-1093.
38. White, P.C. & New, M.I. (1992) Genetic basis of endocrine disease 2: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 74, 6-11.
39. Winkel, C.A., Casey, M.L., Worley, R.J., Madden, J.D. & MacDonald, P.C. (1983) Extraadrenal steroid 21-hydroxylase activity in a woman with congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism, 56, 104-107.
40. Winkel, C.A., Milewich, L., Parker, C.R., Gant, N.F., Simpson, E.R. & MacDonald, P.C. (1980) Conversion of plasma progesterone to deoxycorticosterone in men, non-pregnant and pregnant women and adrenalectomized subjects. Journal of Clinical Investigation, 66, 803-812.